Simfibrate — CAS 14929-11-4

Simfibrate is a symmetric diester of clofibric acid used as a lipid-modifying agent primarily for reducing elevated triglyceride and cholesterol levels. It belongs to the fibrate class of antihyperlipidemic drugs and reduces hepatic VLDL production. Mediocon Inc manufactures GMP-compliant Simfibrate API from its Aurangabad manufacturing unit.

• Hyperlipidemia management
• Triglyceride reduction
• Lipid-lowering formulations
• Cardiovascular risk reduction

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support